Tejara Capital increased its stake in Cardiol Therapeutics, a clinical-stage biopharma company. Monitor for future 13G amendments or a potential conversion to 13D if the fund's intent shifts. The passive certification limits near-term activist expectations.
Price Chart
Executive Summary
Tejara Capital Ltd filed an amended Schedule 13G disclosing a 5.3% passive stake in Cardiol Therapeutics Inc. as of September 2, 2026, representing 6,382,551 Class A Common Shares. This is an increase from the prior filing by Tejara Capital (October 2025), indicating growing conviction from this UK-based fund manager.
Key Financial Metrics
Key Facts
- Tejara Capital Ltd reported beneficial ownership of 6,382,551 Class A Common Shares of Cardiol Therapeutics Inc.
- The stake represents 5.3% of the outstanding shares as of September 2, 2026.
- The filing is an amendment to a prior Schedule 13G, indicating an increase in position.
- Tejara Capital Ltd is a UK-based fund manager authorized by the FCA.
- The filer certifies passive intent under Rule 13d-1(b), not seeking control.
Financial Impact
6,382,551 shares at 5.3% of outstanding — no dollar value disclosed in filing.
Risk Factors
- Passive filing — no indication of activist intent or catalyst for value realization.
- Clinical-stage biotech carries inherent binary risk from pipeline outcomes.
- Stake increase may already be priced in given the filing date lag.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001879713-26-000003 |
| Document: 0001879713-26-000003-index.html | 0001879713-26-000003 |
| Document: 0001879713-26-000003.txt | 0001879713-26-000003 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | SC 13G/A | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 23, 2026 4w ago | 6-K | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 16, 2026 5w ago | 6-K | $1.90 | awaiting T+60 | — | $1.14 (−40.00%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 9, 2026 6w ago | 6-K | $2.29 | awaiting T+60 | — | $1.14 (−50.11%) |
Aug 5, 2026 11w ago | 6-K | $1.34 | awaiting T+60 | — | $1.14 (−14.93%) |
Jul 14, 2026 15w ago | 6-K | $1.15 $1.32 | ▲ +14.78% | ▲ +11.41% | $1.14 (−0.87%) |
Jul 9, 2026 15w ago | 6-K | $0.9920 $1.41 | ▲ +42.14% | ▲ +40.50% | $1.14 (+14.92%) |
May 26, 2026 22w ago | 6-K | $1.30 $1.96 | ▲ +50.77% | ▲ +48.04% | $1.14 (−12.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers